BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 4638102)

  • 1. Potential antiarrhythmic agents. 3. 4-amino-N-(2-(substituted amino)ethyl)-2,6-dimethylbenzamides.
    Yung DK; Lo EK; Vohra MM
    J Pharm Sci; 1972 Dec; 61(12):1953-9. PubMed ID: 4638102
    [No Abstract]   [Full Text] [Related]  

  • 2. Potential antiarrhythmic agents. II. Effects of amide reversal and ortho-methylation on activity of procaine amide.
    Yung DK; Vohra MM; Chu I
    J Pharm Sci; 1970 Oct; 59(10):1405-9. PubMed ID: 5471943
    [No Abstract]   [Full Text] [Related]  

  • 3. Antiarrhythmic agents. Synthesis and biological activity of some tetrazole and oxadiazole analogs of 4-dialkylamino-2,2-diarylbutyramides.
    Adelstein GW
    J Med Chem; 1973 Apr; 16(4):309-12. PubMed ID: 4716173
    [No Abstract]   [Full Text] [Related]  

  • 4. Synthesis and biological evaluation of new cyclopenteno[b]thiophene derivatives as local anesthetic and antiarrhythmic agents.
    al-Obaid AM; el-Subbagh HI; al-Shabanah OA; Mahran MA
    Pharmazie; 1998 Jan; 53(1):24-8. PubMed ID: 9476256
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The potassium channel blocker, dalfampridine diminishes ouabain-induced arrhythmia in isolated rat atria.
    Ghebleh Zadeh N; Vaezi G; Bakhtiarian A; Mousavi Z; Shiravi A; Nikoui V
    Arch Physiol Biochem; 2019 Feb; 125(1):25-29. PubMed ID: 29390872
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Comparative anti-arrhythmia activity of befol, lidocaine, and bonnecor].
    Galenko-Iaroshevskiĭ PA; Khankoeva AI; Uvarov AV; Reznikov AIu; Galygo DS; Bartashevich VV
    Biull Eksp Biol Med; 1996 Dec; 122(12):665-8. PubMed ID: 9280469
    [No Abstract]   [Full Text] [Related]  

  • 7. Anti-arrhythmic properties of 1,5-dimorpholino-3-(1-naphthyl)-pentane (DA 1686).
    Bianchi C; Sanna GP; Turba C
    Arzneimittelforschung; 1968 Jul; 18(7):845-50. PubMed ID: 5755831
    [No Abstract]   [Full Text] [Related]  

  • 8. A comparison of the antiarrhythmic actions of two new synthetic compounds, iproveratril and MJ 1999, with quinidine and pronethalol.
    Schmid JR; Hanna C
    J Pharmacol Exp Ther; 1967 May; 156(2):331-8. PubMed ID: 4381702
    [No Abstract]   [Full Text] [Related]  

  • 9. [Antiarrhythmic properties of 2-(2'-hydroxy-2')-substituted ethyl-1,2,3,4-octahydropyrrolo[1,2-a]pyrazines].
    Filippova OV; Kryzhanovskiĭ SA; Peresada VP; Likhosherstov AM; Revenko SV; Kaverina NV; Reznikov KM
    Eksp Klin Farmakol; 2004; 67(4):26-9. PubMed ID: 15500041
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [New ethylenediamine derivatives with anti-arrhythmic activity].
    Giannini M; Boni P; Fedi M; Bonacchi G
    Farmaco Sci; 1973 Jun; 28(6):429-47. PubMed ID: 4716495
    [No Abstract]   [Full Text] [Related]  

  • 11. Antiarrhythmic activity of some N-alkylbispidinebenzamides.
    Ruenitz PC; Mokler CM
    J Med Chem; 1979 Sep; 22(9):1142-4. PubMed ID: 490563
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preparation, local anaesthetic and antiarrhythmic activity of pyrrolidinomethylcyclohexyl esters of alkoxysubstituted phenylcarbamic acids.
    Búciová L; Cizmárik J; Sedlárová E; Racanská E
    Pharmazie; 1995 Aug; 50(8):566-7. PubMed ID: 7568323
    [No Abstract]   [Full Text] [Related]  

  • 13. Antiarrhythmic actions of coronary vasodilator agents papaverine, dioxyline and verapamil.
    Hanna C; Schmid JR
    Arch Int Pharmacodyn Ther; 1970 Jun; 185(2):228-33. PubMed ID: 5473785
    [No Abstract]   [Full Text] [Related]  

  • 14. [The anti-arrhythmia activity of new dicyclohexylamide derivatives of N-substituted alpha-aminocarboxylic acids].
    Berdiaev SU; Paliani-Katsitadze NSh; Turilova AI; Kaverina NV; Likhosherstov AM; Lebedeva AS; Ogurtsov VA
    Eksp Klin Farmakol; 1999; 62(4):26-9. PubMed ID: 10513331
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Anti-arrhythmic action of N-(aminoalkylene) derivatives of indoline-2,3-diones and 1,2-benzene-dicarboxiamides].
    Stankeviciene LM; Raiziene D; Vyzas V; Janusiene L
    Medicina (Kaunas); 2002; 38(3):312-5. PubMed ID: 12474704
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiarrhythmic action of atropine.
    Viana AP; Osswald W
    Arch Int Pharmacodyn Ther; 1971 Aug; 192(2):238-46. PubMed ID: 4106043
    [No Abstract]   [Full Text] [Related]  

  • 17. [Antiarrhythmic effect of oxylidine].
    Zaĭtseva KA; Mashkovskiĭ MD
    Farmakol Toksikol; 1970; 33(3):305-9. PubMed ID: 4393832
    [No Abstract]   [Full Text] [Related]  

  • 18. Synthesis, cardiac electrophysiology, and beta-blocking activity of novel arylpiperazines with potential as class II/III antiarrhythmic agents.
    Phillips GB; Morgan TK; Lumma WC; Gomez RP; Lind JM; Lis R; Argentieri T; Sullivan ME
    J Med Chem; 1992 Feb; 35(4):743-50. PubMed ID: 1347318
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [2-(2'-hydroxy 2'-substituted) ethyl-1,2,3,4-tetrahydropyrrolo[1,2-a]pyrazines--a novel group of substances with anti-arrhythmia activity].
    Filippova OV; Kryzhanovskiĭ SA; Peresada VP; Likhosherstov AM; Vititnova MB; Kaverina NV; Reznikov KM
    Eksp Klin Farmakol; 2003; 66(3):21-5. PubMed ID: 12924227
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of alkyl substitution in drugs. XIX. Synthesis and pharmacological properties of a series of 1-(diarylmethoxy)-3-(isopropylamino)-2-propanol hydrochlorides showing antiarrhythmic activity.
    De Vries J; Nauta WT; Timmerman H; van Hell G; Mulder D
    Arzneimittelforschung; 1968 Sep; 18(9):1200-3. PubMed ID: 5755937
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.